Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Incannex Healthcare (IXHL) Liabilities and Shareholders Equity: 2020-2025

Historic Liabilities and Shareholders Equity for Incannex Healthcare (IXHL) over the last 2 years, with Sep 2025 value amounting to $78.7 million.

  • Incannex Healthcare's Liabilities and Shareholders Equity rose 390.53% to $78.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $126.5 million, marking a year-over-year increase of 73.95%. This contributed to the annual value of $20.4 million for FY2025, which is 19.94% up from last year.
  • As of Q3 2025, Incannex Healthcare's Liabilities and Shareholders Equity stood at $78.7 million, which was up 285.00% from $20.4 million recorded in Q2 2025.
  • Incannex Healthcare's 5-year Liabilities and Shareholders Equity high stood at $78.7 million for Q3 2025, and its period low was $11.1 million during Q4 2024.
  • In the last 3 years, Incannex Healthcare's Liabilities and Shareholders Equity had a median value of $17.1 million in 2024 and averaged $24.9 million.
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first plummeted by 50.33% in 2024, then skyrocketed by 390.53% in 2025.
  • Over the past 3 years, Incannex Healthcare's Liabilities and Shareholders Equity (Quarterly) stood at $22.4 million in 2023, then tumbled by 50.33% to $11.1 million in 2024, then soared by 390.53% to $78.7 million in 2025.
  • Its Liabilities and Shareholders Equity was $78.7 million in Q3 2025, compared to $20.4 million in Q2 2025 and $16.2 million in Q1 2025.